Avanos Medical, Inc.

Equities

AVNS

US05350V1061

Medical Equipment, Supplies & Distribution

Delayed Nyse Other stock markets 03:45:20 2024-06-11 pm EDT			5-day change	1st Jan Change
19.64 ^USD	+1.71%		-3.40%	-12.35%

May. 13	Avanos Medical, Inc. Appoints Sigfrido Delgado as Senior Vice President, Integrated Supply Chain	CI
May. 02	Avanos Medical to Seek M&A Opportunities	CI

Avanos Medical, Inc. Announces Resignation of Arjun R. Sarker as Senior Vice President, Effective May 10, 2023

February 17, 2023 at 07:35 am EST

Avanos Medical, Inc. announced that on February 14, 2023, Arjun R. Sarker, the Company's Senior Vice President – International, notified the Company that he will resign from his position with the Company, effective May 10, 2023. Mr. Sarker will remain an employee of the Company through May 10, 2023.

Latest news about Avanos Medical, Inc.

Avanos Medical, Inc. Appoints Sigfrido Delgado as Senior Vice President, Integrated Supply Chain	May. 13	CI
Avanos Medical to Seek M&A Opportunities	May. 02	CI
Transcript : Avanos Medical, Inc., Q1 2024 Earnings Call, May 02, 2024	May. 02
Earnings Flash (AVNS) AVANOS MEDICAL Posts Q1 EPS $0.22	May. 02	MT
Avanos Medical, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 02	CI
Avanos Medical, Inc. Provides Earnings Guidance for the Year 2024	May. 02	CI
Avanos Medical, Inc. Announces Voluntary Recall of Mic Gastric - Jejunal Feeding Tube Kits	Feb. 21	CI
Tranche Update on Avanos Medical, Inc.'s Equity Buyback Plan announced on August 1, 2023.	Feb. 21	CI
Transcript : Avanos Medical, Inc., Q4 2023 Earnings Call, Feb 20, 2024	Feb. 20
Earnings Flash (AVNS) AVANOS MEDICAL Reports Q4 EPS $0.23	Feb. 20	MT
Avanos Medical, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	Feb. 20	CI
Avanos Medical, Inc. Provides Earnings Guidance for 2024	Feb. 20	CI
North American Morning Briefing : Earnings Back in -2-	Feb. 20	DJ
Transcript : Avanos Medical, Inc. Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-08-2024 03:45 PM	Jan. 08
Avanos Medical Expects Lower Q4 Net Sales Amid Medicare Pricing Pressures	Jan. 04	MT
Avanos Medical, Inc. Provides Sales Guidance for the Fourth Quarter and Year Ended December 31, 2023 and Year Ending December 31, 2024	Jan. 04	CI
Tranche Update on Avanos Medical, Inc.'s Equity Buyback Plan announced on August 1, 2023.	Nov. 01	CI
Transcript : Avanos Medical, Inc., Q3 2023 Earnings Call, Nov 01, 2023	Nov. 01
Earnings Flash (AVNS) AVANOS MEDICAL Reports Q3 EPS $0.30	Nov. 01	MT
Avanos Medical, Inc. Provides Financial Guidance for the Year 2023	Nov. 01	CI
Avanos Medical, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 01	CI
Avanos Medical Completes Sale of Respiratory Health Business to AirLife	23-10-02	MT
SunMed, LLC acquired Respiratory Health Business from Avanos Medical, Inc. for $110 million.	23-10-01	CI
Avanos Medical Q2 Adjusted Earnings, Revenue Fall	23-08-09	MT
Avanos Medical to Seek Acquisitions	23-08-09	CI

Chart Avanos Medical, Inc.

Duration

Period

More charts

Company Profile

Avanos Medical, Inc. is a medical device company, which is focused on delivering solutions. The Company offers healthcare needs, such as providing nutrition to patients from hospital to home and reducing the use of opioids while helping patients move from surgery to recovery. The Company conducts its business in one segment that provides its medical device products to healthcare providers and patients globally with manufacturing facilities in the United States and Mexico. Its digestive health products include MIC-KEY enteral feeding tubes, Corpak patient feeding solutions and NeoMed neonatal and pediatric feeding solutions. The Companyâs acute pain products include ON-Q and ambIT surgical pain pumps and Game Ready cold and compression therapy systems. The Company's interventional pain solutions include COOLIEF pain therapy and OrthogenRxs knee osteoarthritis pain relief injection products.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-08-05 - Q2 2024 Earnings Release (Projected)

Related indices

Russell 2000

More about the company

Income Statement Evolution

More financial data

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

19.31 USD

Average target price

23.5 USD

Spread / Average Target

+21.70%

Consensus

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
AVANOS MEDICAL, INC.	-12.35%	833M
ABBOTT LABORATORIES	-3.62%	187B
MEDTRONIC PLC	-0.18%	109B
BECTON, DICKINSON AND COMPANY	-3.60%	69.22B
DEXCOM, INC.	-6.00%	46.36B
CENCORA, INC.	+13.19%	46.19B
HOYA CORPORATION	+8.48%	42.44B
METTLER-TOLEDO INTERNATIONAL, INC.	+18.92%	30.84B
TERUMO CORPORATION	+19.69%	25.73B
WEST PHARMACEUTICAL SERVICES, INC.	-7.25%	23.3B

Other Medical Equipment, Supplies & Distribution